State-of-the-Art Management of Advanced Prostate Cancer
In this downloadable slideset, David I Quinn, MD, PhD, provides expert perspective on new therapies for advanced castration-refractory prostate cancer (CRPC), including bone-targeted therapeutic approaches, radiotherapy, and novel agents that block the androgen receptor pathway.

Preventing Bone Compromise in Patients With Nonmetastatic Prostate Cancer
In this downloadable slideset, Matthew R Smith, MD, PhD, provides expert perspective on preventing bone compromise, including effects of androgen-deprivation therapy in patients with prostate cancer, the clinical significance of fractures, and optimal use of bone-directed therapy.

Prevention of Bone Metastases
In this downloadable slideset, Joel B. Nelson, MD, explores current and emerging strategies to prevent bone metastases in patients with prostate cancer.

Therapeutic Strategies for Patients With Prostate Cancer and Bone Metastases
In this downloadable slideset, Michael A. Carducci, MD, covers key current strategies for the optimal treatment of men with bone metastases from prostate cancer, including approved bone-targeted agents and promising drugs in late stages of clinical development.

Overview of Immunotherapy for Oncology Clinicians: Therapeutic Strategies Designed to Leverage the Immune System to Treat Cancer
Antoni Ribas, MD, provides a detailed overview of the history of immunotherapy in the treatment of cancer and explores promising immunotherapy strategies and agents being tested in clinical trials.

Immunomodulatory Therapy for Oncology Clinicians

Preventing Skeletal-Related Events in Patients With Metastasis
Sarah Yenser Wood, RN, MSN, ANP, AOCNP, reviews strategies for preventing skeletal-related events in patients with metastases in this downloadable slideset.

Preventing Recurrence and Delaying Bone Pain With Bone-Targeted Agents
In this downloadable slideset, Pamela Hallquist Viale, RN, MS, CS, ANP, AOCNP, reviews the use of bone-modifying agents for preventing recurrence and delaying bone pain in patients with cancer.

Overall Nursing Considerations With Bone-Directed Agents
Carrie Tompkins Stricker, PhD, RN, explores nursing considerations and management strategies for patients receiving bone-modifying agents in this downloadable slideset.

At a Glance: Bone-Modifying Therapy and Nursing Considerations for Management of Patients With Cancer at Risk for and Experiencing Skeletal-Related Events
Download this pocket resource guide on bone-modifying agents and nursing considerations for patients with or at risk for skeletal-related events.

Multiple Myeloma in Session: An Online Journal Club Resource for Physician Fellows, Edition 1
In this CME-certified learning module, Claudia E. Paba-Prada, MD, and Paul G. Richardson, MD, discuss 3 important randomized trials and relevant case examples on topics related to the treatment of patients with multiple myeloma, including the role of bortezomib-containing regimens as induction and consolidation therapy, thalidomide maintenance therapy, and allogeneic stem cell transplantation.

Multiple Myeloma in Session: An Online Journal Club Resource for Physician Fellows, Edition 2

Multiple Myeloma in Session: An Online Journal Club Resource for Physician Fellows, Edition 3

Selecting Treatment and Management Approaches in Metastatic Breast Cancer
Downloadable slides from an Interactive Virtual Presentation narrated by Kathy D. Miller, MD, which provides a case-based review of optimal and emerging treatment options for patients with metastatic breast cancer.

Optimal Clinical Management of Patients With Chronic Myeloid Leukemia: Proceedings of an Independent Expert Panel
In this unique educational activity, you will be asked to answer specific questions regarding your treatment of patients with chronic myeloid leukemia. After you answer a question, you will then be able to read a multidisciplinary panel of experts’ discussion of that question, including their recommendations for practice.

Chronic Myeloid Leukemia: The Importance of Patient Compliance to TKI Therapy
Join Dragana Milojkovic, MB BS, MRCP, FRCPath, PhD, as she explores the reasons patients have trouble adhering to TKI therapy and how to help increase adherence.

Chronic Myeloid Leukemia: The Importance of Patient Compliance to TKI Therapy
Downloadable slides from an Interactive Virtual Presentation narrated by Dragana Milojkovic, MB BS, MRCP, FRCPath, PhD, which explores patient adherence to TKI therapy and how adherence is associated with molecular and cytogenetic response to therapy.

Optimal Therapeutic Strategies for Chronic Myeloid Leukemia

Chronic Myeloid Leukemia: Expert Guidance on Monitoring Response to First-line Tyrosine Kinase Inhibitor Therapy

Workshop With the Experts: Multiple Myeloma Series 2012
Amitabha Mazumder, MD, and G. David Roodman, MD, PhD, review current assessment and treatment of patients with multiple myeloma in the frontline and relapsed/refractory settings.

Therapeutic Decision Making in Advanced NSCLC: A 2012 Perspective
In this interactive virtual presentation, David R. Gandara, MD, explores clinical factors that should be considered when selecting first-line and maintenance therapy for patients with advanced non-small-cell lung cancer.

Therapeutic Decision Making in Advanced NSCLC: A 2012 Perspective
In this downloadable slideset, David R. Gandara, MD, explores key data supporting treatment decision making for first-line and maintenance therapies in advanced non-small-cell lung cancer.

Expert Guidance in Selecting First-Line and Maintenance Therapy for Advanced NSCLC
Use this Interactive Decision Support Tool to enter your patient’s specific characteristics, and then see what 5 lung cancer experts would choose as their treatment approach.

CCO Independent Conference Coverage of the 2012 Genitourinary Cancers Symposium
Join Daniel P. Petrylak, MD, and David I. Quinn, MD, PhD, as they review the clinical significance of key results presented at the 2012 Genitourinary Cancers Symposium in the areas of prostate cancer, renal cell carcinoma, testicular seminoma, and urothelial cancer.

2012 Genitourinary Cancers Symposium
Join Daniel P. Petrylak, MD, and David I. Quinn, MD, PhD, as they review the clinical significance of key results presented at the 2012 Genitourinary Cancers Symposium in the areas of prostate cancer, renal cell carcinoma, testicular seminoma, and urothelial cancer.

Workshop With the Experts: Colorectal Cancer Series
Downloadable slides highlighting key concepts in colorectal cancer screening and appropriate therapy selection and application in the adjuvant setting and beyond.

Incorporating Biological Insights to Individualize Management of Head and Neck Cancer
In this Interactive Virtual Presentation, Barbara Burtness, MD, provides a case-based overview of the latest findings on optimal management of patients with squamous cell carcinoma of the head and neck.

Incorporating Biological Insights to Individualize Management of Head and Neck Cancer
Barbara Burtness, MD, explores key issues related to the management of head and neck squamous cell carcinoma, including prognostic and predictive markers and the latest clinical data on the optimal management of locoregionally advanced and metastatic disease.

2012 Gastrointestinal Cancers Symposium
Thomas H. Cartwright, MD, and Alan P. Venook, MD, discuss the clinical implications of results of studies presented at the 2012 Gastrointestinal Cancers Symposium.

Pancreatic Cancer: Evolving Best Practices and Promising Novel Agents
In this Interactive Virtual Presentation, Andrew H. Ko, MD, provides expert perspective on current optimal treatment of pancreatic cancer.

Pancreatic Cancer: Evolving Best Practices and Promising Novel Agents
Andrew H. Ko, MD, explores current optimal treatment and future direction in the treatment of pancreatic cancer.

Chronic Myeloid Leukemia Treatment in Evolution: Recent Advances in Tyrosine Kinase Inhibitor Therapy
This brief interactive activity with case-based in-page polling provides today’s busy clinicians with practical insights from Moshe Talpaz, MD, on the selection of tyrosine kinase inhibitors for patients with CML in both the first-line and salvage settings based on the most recently reported data.

Management of a Patient With Newly Diagnosed Metastatic Melanoma
In this challenging interactive case study, Keith T. Flaherty, MD, explores the use of newly approved agents to treat a patient with metastatic melanoma.

Independent Expert Panel in Malignant Melanoma: Improving Physician Performance to Enhance Patient Outcomes 
In this interactive CME-certified activity, a panel of experts discusses management options and the supporting evidence for the treatment of advanced unresectable and metastatic melanoma based on clinical issues highlighted by a survey on current practices of healthcare providers caring for these patients.

Lymphomas
In this CME-certified slideset, James O. Armitage, MD; Richard I. Fisher, MD; and Julie M. Vose, MD, review the most clinically relevant new data on lymphoma management from the 2011 American Society of Hematology annual meeting.

Update on Multiple Myeloma
In this CME-certified slideset, Kenneth Anderson, MD; Sagar Lonial, MD; and Amitabha Mazumder, MD, review the latest data in the treatment of multiple myeloma presented at the 2011 American Society of Hematology Annual Meeting in San Diego.

Myelodysplastic Syndromes and Acute Leukemia
In this downloadable slideset with slidenotes, Martin S. Tallman, MD; Farhad Ravandi, MD; and Alan F. List, MD, provide an overview of the clinical implications of key data in the treatment of myelodysplastic syndromes and acute leukemias presented at the 2011 American Society of Hematology Annual Meeting.

Chronic Myeloid Leukemia
In this CME-certified slideset, Elias Jabbour, MD and Jerald Radich, MD, provide an analysis of key data in the treatment of chronic myeloid leukemia presented at the 2011 American Society of Hematology Annual Meeting.

Chronic Lymphocytic Leukemia
In this CME-certified slideset, John C. Byrd, MD, and Kanti Rai, MD, explore the most compelling data in chronic lymphocytic leukemia presented in San Diego.

Nonmalignant Hematology Disorders and ITP: Update
In this CME-certified slideset, Terry Gernsheimer, MD, and Howard Liebman, MD, FACP, review the most clinically relevant new data on nonmalignant hematology disorders presented at the 2011 annual meeting of the American Society of Hematology.

Lymphomas
In this downloadable slideset, James O. Armitage, MD; Richard I. Fisher, MD; and Julie M. Vose, MD, review the most important abstracts in lymphomas presented at the 2011 American Society of Hematology Annual Meeting.

Nonmalignant Hematology Disorders and ITP
In this downloadable slideset, Terry Gernsheimer, MD, and Howard Liebman, MD, FACP, review the latest data in the treatment of nonmalignant hematology disorders and ITP presented at the 2011 American Society of Hematology annual meeting.

Myelodyplastic Syndromes and Acute Leukemias
In this downloadable slideset, Alan F. List, MD, Farhad Ravandi, MD, and Martin S. Tallman, MD, provide an overview of the key data in the treatment of myelodysplastic syndromes and acute leukemias presented at the 2011 American Society of Hematology Annual Meeting.

Update on Multiple Myeloma
In this downloadable slideset, Kenneth Anderson, MD, Sagar Lonial, MD, and Amitabha Mazumder, MD, review the latest data in the treatment of multiple myeloma presented at the 2011 American Society of Hematology Annual Meeting. 

Chronic Myeloid Leukemia
In this downloadable slideset, Elias Jabbour, MD and Jerald Radich, MD, provide an overview of key data in chronic myeloid leukemia presented at the 2011 Annual Meeting of the American Society of Hematology. 

Chronic Lymphocytic Leukemia
In this downloadable slideset, John C. Byrd, MD, and Kanti Rai, MD, review the most compelling data in the treatment of chronic lymphocytic leukemia presented at the 2011 American Society of Hematology Annual Meeting.

A Moment to Own It: Metastatic Breast Cancer Treatment in Evolution
In this case discussion, Kathy D. Miller, MD, and Linda T. Vahdat, MD, review the most clinically relevant new findings in metastatic breast cancer and how these data influence treatment decisions in 4 clinical case scenarios.

Conference Report: 2011 Combined Meeting of the Connective Tissue Oncology Society and the Musculoskeletal Tumor Society
R. Lor Randall, MD, FACS, and Richard Riedel, MD, discuss key findings in osteosarcomas, soft-tissue sarcomas, and desmoid tumors from the 2011 Combined Meeting of the Connective Tissue Oncology Society and the Musculoskeletal Tumor Society.

Current Evidence-Based Management of Stage II-IV Colon Cancer: Practice in Evolution
In this interactive, case-based module, participants can quickly assess the summarized key points, compare management choices in various clinical scenarios involving patients with stage II-IV colon cancer with those of Richard M. Goldberg, MD, and John L. Marshall, MD, and then review a concise discussion of the evidence supporting their management decisions.

Bone-Targeted Therapy in the Treatment of Bone Metastases
In a case-based presentation, Alison T. Stopeck, MD, highlights the data important to guide choice of bone-targeted therapy for patients with bone metastases from breast cancer.

Use of Bone-Targeted Agents to Treat or Prevent Cancer Therapy-Induced Bone Loss
Julie R. Gralow, MD, provides an overview of clinical trial data and guideline recommendations on the use of bone-targeted agents to prevent bone loss in patients with early-stage breast cancer.

Bone-Targeted Therapy in Early Breast Cancer: Preventing Disease Recurrence
In this presentation Robert E. Coleman, MD, FRCP, reviews the latest clinical trial data on the role of adjuvant bisphosphonates in early stage breast cancer and provides guidance on which subsets of patients may benefit most from this treatment strategy.

An Update on Early Breast Cancer
In this CME-certified slideset, Joyce O’Shaughnessy, MD, and Peter Ravdin, MD, PhD, provide an overview of key early breast cancer data presented at the 2011 Annual Meeting of the AACR-CTRC San Antonio Breast Cancer Symposium.

An Update on Metastatic Breast Cancer
In this CME-certified slideset, William J. Gradishar, MD, FACP, and Kathy D. Miller, MD, provide an analysis of key data on metastatic breast cancer presented at the 2011 Annual Meeting of the AACR-CTRC San Antonio Breast Cancer Symposium.

An Update on Early Breast Cancer
In this downloadable slideset, Joyce O’Shaughnessy, MD and Peter Ravdin, MD, PhD, provide an overview of key early breast cancer data presented at the 2011 Annual Meeting of the AACR-CTRC San Antonio Breast Cancer Symposium.

An Update on Metastatic Breast Cancer
In this downloadable slideset, William J. Gradishar, MD, FACP and Kathy D. Miller, MD, provide an overview of key data presented at the 2011 Annual Meeting of the AACR-CTRC San Antonio Breast Cancer Symposium.

Updates in Community Oncology 2011: A Focus on Melanoma
Downloadable slides designed to improve patient care in the community practice setting by highlighting clinically relevant changes in the treatment of melanoma.

Expert Commentary: Key Concepts in Multiple Myeloma
In this Expert Commentary, Amitabha Mazumder, MD, reviews the latest information on the diagnosis and treatment of multiple myeloma in different patient populations.

Key Concepts in Recent Data in Multiple Myeloma
In this downloadable slideset, Amitabha Mazumder, MD, reviews recent data in the treatment of multiple myeloma.

A Moment to Own It: Multiple Myeloma
In this expert discussion, Amitabha Mazumder, MD; Jonathan L. Kaufman, MD; Tomer Martin Mark, MD; and David H. Vesole, MD, review recent data in the treatment of multiple myeloma.

Therapeutic Options for Advanced NSCLC: First Line
Downloadable slideset providing an overview of key data and recommendations for first-line therapy to assist clinicians treating patients with non-small-cell lung cancer.

Therapeutic Options for Advanced NSCLC: Maintenance
Downloadable slides providing an overview of key data and recommendations for maintenance therapy to assist clinicians treating patients with non-small-cell lung cancer.

Therapeutic Options for Advanced NSCLC: Second Line
Downloadable slides providing an overview of key data and recommendations for second-line therapy to assist clinicians treating patients with non-small-cell lung cancer.

GBM: Scope of the Clinical Issue
Timothy Cloughesy, MD, provides an overview of the scope of glioblastoma, including risk factors, biomarkers, and cancer care coordination.

Current Treatment Options for Glioblastoma
Tracy Batchelor, MD, MPH, provides an overview of treatment of newly diagnosed and recurrent glioblastoma.

Patient Assessment, Supportive Care, and Management of Adverse Events
Patrick Y. Wen, MD, provides an overview of patient assessment, supportive care, and management of adverse events in glioblastoma.

Biomarkers for Prognosis and Prediction in Advanced NSCLC
Watch, listen, and test your knowledge as Howard (Jack) West, MD, discusses the value of biomarkers in NSCLC.

Therapeutic Strategies: EGFR-Targeted Agents in Advanced NSCLC
Watch, listen, and test your knowledge as George R. Simon, MD, FACP, FCCP, discusses the latest data on EGFR-targeted therapies in NSCLC.

Biomarkers for Prognosis and Prediction in Advanced NSCLC
Howard (Jack) West, MD, discusses the value of biomarkers in NSCLC.

Therapeutic Strategies: EGFR-Targeted Agents in Advanced NSCLC
George R. Simon, MD, FACP, FCCP, discusses the latest data on EGFR-targeted therapies in NSCLC.

Conference Report: 2011 World Conference on Lung Cancer
David R. Gandara, MD, and Giuseppe Giaccone, MD, PhD, discuss the most clinically relevant new findings in lung cancer from the 2011 World Conference on Lung Cancer.

Expert Guidance in the Treatment of CRPC: Making the Right Choices for Patients
Using interactive case scenarios and a new online Interactive Decision Support Tool, David I. Quinn, MD, PhD, discusses management strategies using current therapeutic options for patients with metastatic castration-resistant cancer.

Expert Guidance in the Treatment of CRPC: Making the Right Choices for Patients
In this downloadable slideset, David I. Quinn, MD, PhD, highlights expert recommendations and clinical trial evidence for the management of patients with castration-resistant prostate cancer.

Expert Guidance in the Treatment of CRPC: Making the Right Choices for Patients
Use this interactive decision support tool with simple pulldown menus to enter your patient’s specific characteristics along with the treatment options you would likely choose for the treatment of castration-resistant prostate cancer. Then view the preferred choices of 5 prostate cancer experts via a graphical Expert Insight display and assess if the expert choices affect your own decision making.

Tailoring Therapy for Multiple Myeloma to Improve Patient Outcomes: Treatment Strategies for Transplant-Eligible Patients With Multiple Myeloma
In this downloadable slideset, Kenneth Anderson, MD, Sagar Lonial, MD, and Paul G. Richardson, MD, review the latest information on the treatment of transplant-eligible patients with multiple myeloma.

Tailoring Therapy for Multiple Myeloma to Improve Patient Outcomes: Treatment Strategies for Patients Not Eligible for Transplantation
In this downloadable slideset, Kenneth Anderson, MD, Sagar Lonial, MD, and Paul G. Richardson, MD, review the latest information on the treatment of transplant-ineligible patients with multiple myeloma.

Tailoring Therapy for Multiple Myeloma to Improve Patient Outcomes: Optimal Salvage Treatment for Relapsed/Refractory Multiple Myeloma
In this downloadable slideset, Kenneth Anderson, MD, Sagar Lonial, MD, and Paul G. Richardson, MD, review the latest information on the treatment of patients with relapsed/refractory multiple myeloma.

Clinical Advances in Follicular Lymphoma
Downloadable slides providing evidence-based treatment strategies for a patient with follicular lymphoma.

Evolving Therapies in Mantle Cell Lymphoma
Downloadable slides providing evidence-based treatment strategies for a patient with mantle cell lymphoma.

Optimizing Treatments for Peripheral T-Cell Lymphoma
Downloadable slides providing evidence-based treatment strategies for a patient with peripheral T-cell lymphoma.

Personalizing Therapy of Advanced-Stage NSCLC: 2011 Looking Toward 2015
David R. Gandara, MD, discusses and demonstrates, using interactive case scenarios, how the use of biomarkers play an important role in the management of patients with advanced stage NSCLC.

Personalizing Therapy of Advanced-Stage NSCLC: 2011 Looking Toward 2015
Downloadable slides from Interactive Virtual Presentation reviewing key clinical considerations for individualized care of patients with advanced NSCLC.

Managing Patients With Bone Metastases
Throughout this interactive activity, you will be prompted with engaging clinical practice questions and scenarios as Pamela Hallquist Viale, RN, MS, CS, ANP, AOCNP, discusses nursing management strategies for the care of patients with bone metastases from cancer.

Managing Bone Loss and Osteoporosis in the Cancer Patient
In this interactive activity, Carrie Tompkins Stricker, PhD, RN, discusses nursing management strategies for the care of patients at risk for bone loss and clinical fractures. By participating, you will answer challenging multiple-choice questions designed to help you learn more and improve your competence in different clinical scenarios related to this subject.

The Role of the Oncology Nurse in Managing Skeletal Complications: Making Optimal Choices for Improving Patient Care
In this downloadable slideset, Carrie Tompkins Stricker, PhD, RN highlights important nursing considerations in the management of patients with cancer at risk for or with bone loss/osteoporosis or bone metastases.

Risk Assessment, Treatment, and Patient Counseling for Managing Cancer-Related Skeletal Complications
Download this point-of-care pocket resource as an aid in the management of your patients with cancer who are at risk for or experiencing bone loss or bone metastases.

Optimizing Bone Health in Patients With Cancer: Proceedings of an Independent Expert Panel
In this unique educational activity, you will be asked to answer specific questions regarding your use of bone-targeted agents in the treatment of patients with cancer. After you answer a question, you then will be able to read a multidisciplinary panel of experts’ discussion of that question, including their recommendations for practice.

Mitigating Bone Complications in Multiple Myeloma
In this interactive educational activity, G. David Roodman, MD, PhD, uses patient cases to illustrate best practice in the care of patients with myeloma bone disease.

Protecting Bone for Men With Prostate Cancer
In this interactive educational activity, Evan Y. Yu, MD, uses patient cases to illustrate best practice in the identification of patients in need of bone-targeted therapy, management of bone metastases, and use of bone-targeted agents to prevent bone metastases in men with prostate cancer.

Managing Skeletal-Related Events in Patients With Breast Cancer
In this interactive educational activity, Katherine N. Weilbaecher, MD, suggests evidence-based therapeutic strategies to help protect the skeleton of patients with breast cancer.

Optimizing Bone Health in Patients With Cancer: Proceedings of an Independent Expert Panel
Downloadable slides highlighting clinical trial data and expert recommendations important to guide the use of bone-targeted agents in the treatment of patients with cancer.

Mitigating Bone Complications in Multiple Myeloma
Downloadable slides from Interactive Virtual Presentation reviewing best practice in the care of patients with myeloma bone disease.

Protecting Bone for Men With Prostate Cancer
Downloadable slides from Interactive Virtual Presentation reviewing evidence-based therapeutic strategies to prevent and manage skeletal complications in patients with prostate cancer.

Managing Skeletal-Related Events in Patients With Breast Cancer
Downloadable slides from Dr. Weilbaecher’s case-based presentation reviewing the latest clinical evidence and expert recommendation on the optimal use of bone-targeted agents in the care of patients with breast cancer.

Expert Guidance on Bone-Targeted Therapy for Patients With Breast Cancer
This Interactive Decision Support Tool will allow you to view 5 breast cancer experts’ preferred choice of bone-targeted agents based on your patient’s specific characteristics that you can enter with just a few clicks through pull-down menus.

Expert Guidance on Bone-Targeted Therapy for Patients With Prostate Cancer
This Interactive Decision Support Tool will allow you to view 5 prostate cancer experts’ preferred choice of bone-targeted therapy based on your patient’s specific characteristics that you can enter with just a few clicks through pull-down menus.

Novel Targets in Hematologic Malignancies: Translating Clinical Trials and Research Into Patient Care
Watch, listen, and test your knowledge as Richard R. Furman, MD, reviews the latest information on novel targets in hematologic malignancies.

Novel Targets in Hematologic Malignancies: Translating Clinical Trials and Research Into Patient Care 
In this downloadable slideset, Richard R. Furman, MD, reviews the latest information on novel targets in hematologic malignancies.

Individualizing Therapy to Optimize Patient Outcomes in MDS
In this downloadable slideset, Alan F. List, MD, and Rami Komrokji, MD review the most recent data in MDS therapies and supportive care.

The Right Care for the Younger Patient: Meeting the Needs of Adolescents and Young Adults With Cancer
Leonard S. Sender, MD, discusses the specific medical, emotional, and psychosocial needs of adolescent and young adults with cancer and reviews best practices in specific tumor types for this patient population.

The Right Care for the Younger Patient: Meeting the Needs of Adolescents and Young Adults With Cancer
In this downloadable slideset, Leonard S. Sender, MD, explores adolescent and young adult oncology as a subspecialty and reviews best practices for key malignancies in this population.

Expert Insight in CML: Current Critical Issues in Primary Treatment, Evaluation, and Second-line Therapy 
In this interactive CME-certified activity, compare your management of a patient with chronic myeloid leukemia as he progresses from newly diagnosed to advanced disease with evidence-based treatment strategies and perspectives from a roundtable among Jerald Radich, MD; Michael J. Mauro, MD; and B. Douglas Smith, MD.

Expert Insight in CML: Current Critical Issues in Primary Treatment, Evaluation, and Second-line Therapy
Download a slideset by Jerald P. Radich, MD that captures highlights from a case-based roundtable discussion between 3 experts on the management of CML.

Evolving Treatment Paradigms in DLBCL
Julie M. Vose, MD, explores current thinking, recent clinical trial data, and future research directions in the treatment of diffuse large B-cell lymphoma.

Current and Emerging Treatment Options for Follicular Lymphoma
Christopher R. Flowers, MD, explores current thinking and case studies in the treatment of follicular lymphoma.

Current Treatment Options in Waldenström’s Macroglobulinemia
Steven P. Treon, MD, MA, PhD, uses case studies to highlight current thinking regarding optimal treatment of patients with Waldenström’s macroglobulinemia.

Mantle Cell Lymphoma: Standard and Future Therapies
Steven H. Bernstein, MD, explores current thinking regarding optimal treatment of patients with mantle cell lymphoma.

Evolving Treatment Paradigms in DLBCL
Julie M. Vose, MD, explores current thinking, recent clinical trial data, and future research directions in the treatment of diffuse large B-cell lymphoma.

Current and Emerging Treatment Options for Follicular Lymphoma
Christopher R. Flowers, MD, explores current thinking and case studies in the treatment of follicular lymphoma.

Current Treatment Options in Waldenström’s Macroglobulinemia
Steven P. Treon, MD, MA, PhD, uses case studies to highlight current thinking regarding optimal treatment of patients with Waldenström’s macroglobulinemia.

Mantle Cell Lymphoma: Standard and Future Therapies
Steven H. Bernstein, MD, explores current thinking regarding optimal treatment of patients with mantle cell lymphoma.

Managing Skeletal-Related Events in Patients With Cancer: A Master Class in Breast Cancer, Prostate Cancer, and Multiple Myeloma
Downloadable slides from the 2011 Master Class symposium on bone health in patients with breast cancer, prostate cancer, and multiple myeloma.

Highlights From the 2011 Clinical Oncology Meeting 
Download slides on the most compelling data presented at the 2011 Clinical Oncology Meeting in Chicago, Illinois.

Setting the Stage: State of the Art in First-line Treatment of Metastatic or Recurrent NSCLC
Download slides focused on frontline treatment options for patients with metastatic or recurrent NSCLC.

Expanding the Targets: Understanding the Role of Selected Critical Signaling Pathways in NSCLC
Download slides focused on novel and emerging agents targeting therapeutically-relevant proangiogenic signaling pathways in NSCLC.

Expanding the Opportunities for Care: Targeting Proangiogenic Pathways in NSCLC
Download slides focused on clinical opportunities for agents targeting therapeutically-relevant proangiogenic signaling pathways in NSCLC.

Targeting Proangiogenic Pathways in Non-Small-Cell Lung Cancer: Current and Future Directions
In this interactive discussion, Vincent A. Miller, MD; John V. Heymach, MD, PhD; David R. Spigel, MD; and Heather Wakelee, MD, discuss the latest data on proangiogenic pathways in NSCLC.

Optimal Integration of New Treatments for Castration-Resistant Prostate Cancer
Download highlight slides from a recent ASCO satellite symposium focused on the current treatment of patients with castration-resistant prostate cancer. Topics include targeting androgens, new chemotherapies, new immunotherapies, and managing skeletal complications.

New Directions in the Treatment of Patients With HER2-Positive Breast Cancer
Dennis J. Slamon, MD, PhD, and Sara Hurvitz, MD, provide a case-based review of the latest clinical data on the treatment of patients with HER2-positive breast cancer.

New Directions in the Treatment of Patients With HER2-Positive Breast Cancer
Dennis J. Slamon, MD, PhD, and Sara Hurvitz, MD, provide a case-based review of the latest clinical data on the treatment of patients with HER2-positive breast cancer.

Strategies for Incorporating Targeted Therapies into Evolving Treatment Algorithms for NSCLC
In this download able slideset, David R. Gandara, MD, provides an overview of the latest clinical trial data on the use of biomarkers in the treatment of patients with non-small-cell lung cancer.

The Role of the Oncology Nurse in Preventing and Managing Skeletal-Related Events in Patients With Cancer
Download slides focused on nursing management strategies for treating patients with breast cancer, prostate cancer, or multiple myeloma experiencing bone loss/osteoporosis or bone metastases.

Re-Evaluating Your Practice: Managing Skeletal-Related Events in Patients with Prostate Cancer
Download highlight slides from a recent AUA satellite symposium focused on bone-targeted therapies and bone health in patients with prostate cancer who are at risk of skeletal-related events from androgen deprivation therapy and bone metastases.